biomedicina slovenica


"GOSERELIN" : 7

  1. De Laurentiis Michelino; Borštnar Simona
    Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population
    2021
  2. Jelen-Jurič Jožica; Umičević Snežana; Vrhovnik Kristina; Zakotnik Branko
    Subkutana aplikacija goserelina (Zoladex) - implantanta s podaljšanim sproščanjem
    2006
  3. Hodolič Marina; Maffione Anna Margherita; Fettich Jurij; Gubina Borut; Cimitan Marino; Rubello Domenico
    Metastatic Prostate Cancer Proven by 18F-FCH PET/CT Staging Scan in Patient With Normal PSA but High PSA Doubling Time
    2012
  4. Jagodič Klemen; Bizjak Igor; Erklavec Marko; Poteko Sandi; Korošec Helena; Kmetec Andrej; Tršinar Bojan
    Quality of life in patients with prostate cancer treated with LH-RH agonists
    2008
  5. Goldhirsch A; Lindtner J; Eržen D; Majdič E; Štabuc B; Plesničar A; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial
    2003
  6. Vlaisavljević Veljko; Reljić Milan; Gavrić-Lovrec Vida; Kovačič Borut
    Comparable effectiveness using flexible single-dose GnRH antagonist (centrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles - a prospective, randomized study
    2003
  7. Castiglione-Gertch M; O'Neill A; Gelber RD; Nasi ML; Rabaglio M; Lindtner J; Crivellari D; Forbes J; Fey M; Perey L
    Is the addition of adjuvant chemotherapy always necessary in node negative (N-) pre/perimenopausal breast cancer patients (pts) who recive goserelin?
    2002


Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko